Medical/Pharmaceuticals

Zeus Invests in Global Expansion Program to Increase Catheter Manufacturing Capacity

ORANGEBURG, S.C., June 21, 2022 /PRNewswire/ -- Zeus, the global leader in advanced polymer solutions, today announced a multi-million dollar investment to expand its catheter manufacturing capacity worldwide. The first phase of the expansion program is already underway at the company'sSan Jose l...

2022-06-21 20:00 1368

Apowiser Raises $1.5M In Seed Funding from Longliv Ventures, a Member of CK Hutchison Holdings, to Expand the Global Reach of its Novel Digital Platform that Empowers Consumers to make Informed Choices when Selecting Over-the-Counter Medications

RA'ANANA, Israel, June 21, 2022 /PRNewswire/ -- Apowiser , an early-stage Israeli start-up that has developed PharmAssist , a chatbot-based system to support customers in the online purchase of Over-the-Counter (OTC) drugs a...

2022-06-21 19:00 2090

Fosun's Innovative Achievements Continue to Make Breakthroughs

Thanks to its Robust Global Ecosystem, Fosun's Various Business Segments Continue to Achieve Growth HONG KONG, June 21, 2022 /PRNewswire/ -- With the resumption of work, production, and business operations inShanghai, the 4th 515 Fosun Family Day, which has been ongoing for more than a month, us...

2022-06-21 17:04 2009

Nippon Express Launches New Transport Service Using Environment-friendly Isothermal Packaging

-First Japanese Logistics Company to Collaborate with EMBALL'ISO, Experienced in Vaccine Transport- TOKYO, June 21, 2022 /PRNewswire/ -- Nippon Express Co., Ltd., a group company of Nippon Express Holdings, Inc., has become the first Japanese logistics company to collaborate with EMBALL'ISO, a F...

2022-06-21 14:00 1488

Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-Line Treatment for Esophageal Squamous Cell Carcinoma

SAN FRANCISCO, INDIANAPOLIS and SUZHOU, China, June 21, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic, opht...

2022-06-21 08:00 2678

Onward Therapeutics Made a Second Strategic Equity Investment in Emercell for Their NK Cell Technology in Cancer Immunotherapy

EPALINGES, Switzerland and MONTPELLIER, France, June 20, 2022 /PRNewswire/ -- Onward Therapeutics SA (Onward Therapeutics) and Emercell SAS (Emercell) announced today the recent exercise of Onward Therapeutics' second of three instalments of equity investment in Emercell. With this investment, On...

2022-06-20 12:00 1743

SoniVie receives IDE approval from FDA for its Pilot study to treat Hypertension with its Renal Artery Denervation TIVUS™ technology

TEL AVIV, Israel, June 20, 2022 /PRNewswire/ -- SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound System (TIVUS™) to treat a variety of hypertensive disorders, announced that on May 5th 2022 the U.S. Food and Drug Administration granted IDE approval ...

2022-06-20 10:00 1851

Casio to Release Dermatology Camera and Scope in Europe

Following Completion of EU Declaration of Conformity to European MDR TOKYO, June 17, 2022 /PRNewswire/ -- Casio Computer Co., Ltd. announced today that the DZ-D100 Dermatology Camera and DZ-S50 Dermatology Scope conformity studies for European Medical Device Regulations (MDR) have been completed ...

2022-06-17 09:00 1697

Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis

HONG KONG, June 17, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, is pleased to announce that Cellenkos, Inc. ("CLNK"...

2022-06-17 04:20 2810

Insilico Medicine appoints Dr. Feng Ren as co-CEO

Dr. Feng Ren, Chief Scientific Officer (CSO) and head of global research and development is named co-CEO of Insilico Medicine Highlights: * Insilico Medicine is a global, end-to-end, fully-integrated AI-powered biotechnology company with three business models: AI platform, collaboration, and ...

2022-06-16 21:03 3513

Global Cord Blood Corporation Announces Purported EGM Is Not Validly Convened

HONG KONG, June 16, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO, "GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, noticed that onJune 3, 2022 Blue Ocean Structure Inv...

2022-06-16 20:30 4210

New research reveals the critical actions needed to ensure COVID-19-driven surge in virtual health and care drives health access and equity in Asia

* COVID-19 pandemic triggered massive surge in virtual health and care delivery across the world, with regions includingAsia embracing hybrid virtual and in-person services * Report from the Broadband Commission for Sustainable Development Working Group on Virtual Health and Care – co-chair...

2022-06-16 15:45 1918

Global Pharmaceutical Market Drives Innovative Digitalization to Accelerate Drug Discovery

According to Frost & Sullivan, digitalization across the pharmaceutical value chain will improve the industry´s efficiency. SAN ANTONIO, June 16, 2022 /PRNewswire/ -- Frost & Sullivan's recent analysis, Global Pharmaceuticals Outlook, finds that the accelerated drug development timelines are driv...

2022-06-16 15:12 1931

Implantica Applauded by Frost & Sullivan for Transforming Gastroesophageal Reflux Disease Treatment with Its Revolutionary Implant RefluxStop™

The RefluxStop™ device prevents the regurgitation of stomach fluid into the esophagus and addresses the limitations of proton pump inhibitors (PPIs) and existing surgical methods and devices for treating acid reflux disease. SAN ANTONIO, June 16, 2022 /PRNewswire/ --– Frost & Sullivan recently a...

2022-06-16 14:00 1593

Sirnaomics Announces Publication of STP705 Clinical Study Results for Treatment of isSCC in the Peer-Reviewed Journal of Drugs in Dermatology

GAITHERSBURG, Md. and SUZHOU, China, June 16, 2022 /PRNewswire/ -- Sirnaomics Ltd. ("Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced the peer-reviewed publication of Phase IIa clinical study results of its lead th...

2022-06-16 13:01 2129

GILEAD SCIENCES NEW DATA HIGHLIGHTS PEOPLE LIVING WITH HIV WHO ARE VIRALLY SUPPRESSED EXPERIENCE SIMILAR HEALTH-RELATED QUALITY OF LIFE AS GENERAL POPULATION

– Data in Taiwan Shows That Antiretroviral Therapies Have Helped Transform HIV Into a Chronic Condition and Bring Positive Change in the Outlook for People Living with HIV– SINGAPORE, June 16, 2022 /PRNewswire/ -- Gilead Sciences, Inc. today announced results from an online survey that assessed ...

2022-06-16 11:15 2264

Ascletis Announces Oral Presentation on Updates from Phase IIb Clinical Trial of ASC22, a Subcutaneous PD-L1 Antibody for Functional Cure of Chronic Hepatitis B at EASL ILC 2022

- The updates of ASC22 Phase IIb study will be presented at the oral session during the International Liver Congress™ 2022 onSaturday, June 25, 2022 at 14:15 , Beijing Time (Abstract Number: OS091) HANGZHOU, China and SHAOXING, China, June 16, 2022 /PRNewswire/ --  Ascletis Pharma Inc. (HKEX:1672...

2022-06-16 08:10 2320

Novotech and Medidata expand partnership to continue advancements in clinical research

Leading Asia-Pacific biotech specialist CRO Novotech and Medidata renew partnership, further expanding services to Novotech clients in APAC and the US SINGAPORE, June 16, 2022 /PRNewswire/ -- Medidata, a Dassault Systèmes company, today announced its renewed, expanded partnership with Novotech, a...

2022-06-16 08:00 2261

Mindray Reimagines Point of Care Systems with Launch of New TEX20 Diagnostic Ultrasound Series at Euroanaesthesia 2022

SHENZHEN, China, June 15, 2022 /PRNewswire/ -- Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has launched its best-in-class Point of Care ultrasound system TEX20 Series

2022-06-15 21:17 3015

AnchorDx's Non-invasive Lung Cancer Early Diagnosis Product, PulmoSeek, Completes EU CE Marking Requirements

The company obtained a European Access Permit for in-vitro diagnostics devices (IVDD) authorized by the Netherlands CIBG of Ministry of Health, Welfare and Sport. GUANGZHOU, China, June 15, 2022 /PRNewswire/ -- PulmoSeekTM Lung Cancer Early Detection Assay, the non-invasive blood-based cfDNA met...

2022-06-15 21:00 1952
1 ... 134135136137138139140 ... 381

Week's Top Stories